HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diarrhea D003967 32 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Sarcoma D012509 3 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Seshadri T et al. Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. 2006 Br. J. Cancer pmid:16570049
Barshishat M et al. Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line. 2002 Br. J. Cancer pmid:12439723
Beau-Faller M et al. Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping. 2009 Br. J. Cancer pmid:19293811
Berney DM et al. Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. 2009 Br. J. Cancer pmid:19293807
Beskow C et al. Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB-IIA of cervical cancer. 2006 Br. J. Cancer pmid:16685270
Kawanishi H et al. Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation. 2007 Br. J. Cancer pmid:17579624
Mekenkamp LJ et al. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. 2010 Br. J. Cancer pmid:20551951
Ishikawa K et al. Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer. 2008 Br. J. Cancer pmid:18506187
Bilim V et al. Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma. 2009 Br. J. Cancer pmid:19920820
Hamma-Kourbali Y et al. Carboxymethyl benzylamide dextran inhibits angiogenesis and growth of VEGF-overexpressing human epidermoid carcinoma xenograft in nude mice. 2003 Br. J. Cancer pmid:12838326
Trinh XB et al. The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. 2009 Br. J. Cancer pmid:19240722
Yao H et al. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer. 2004 Br. J. Cancer pmid:15494722
Pardo FS et al. Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage. 2004 Br. J. Cancer pmid:15494720
Tang Z et al. Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer. 2008 Br. J. Cancer pmid:19238632
Kristiansen G et al. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. 2003 Br. J. Cancer pmid:12610508
Hussain SA et al. Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder. 2003 Br. J. Cancer pmid:12592374
Spizzo G et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. 2003 Br. J. Cancer pmid:12592372
Townsley CA et al. Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer. 2006 Br. J. Cancer pmid:16570047
Baldewijns MM et al. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. 2007 Br. J. Cancer pmid:17505508
Pattje WJ et al. The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer. 2010 Br. J. Cancer pmid:20502457
Kim MS et al. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. 2008 Br. J. Cancer pmid:18392055
Moniaux N et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. 2008 Br. J. Cancer pmid:18392050
Shrout J et al. beta(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients. 2008 Br. J. Cancer pmid:18506145
Andersen CL et al. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. 2009 Br. J. Cancer pmid:19156145
Kronqvist P et al. Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer. 2002 Br. J. Cancer pmid:12439717
Sersa G et al. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. 2002 Br. J. Cancer pmid:12434299
Fan LZ and Cherian MG Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. 2002 Br. J. Cancer pmid:12434295
de Micco C et al. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. 2008 Br. J. Cancer pmid:18212751
Wang Y et al. Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours. 2006 Br. J. Cancer pmid:16479254
Thews O et al. Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia. 2004 Br. J. Cancer pmid:15305198
Yao M et al. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer. 2002 Br. J. Cancer pmid:12189559
Gaballah K et al. The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues. 2009 Br. J. Cancer pmid:19623179
Wülfing P et al. Expression of endothelin-A-receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer. 2004 Br. J. Cancer pmid:15226779
Elie C et al. Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group). 2004 Br. J. Cancer pmid:15226774
Ogawa E et al. Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. 2004 Br. J. Cancer pmid:15226767
Collet JF et al. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. 2005 Br. J. Cancer pmid:16251880
Ben-Izhak O et al. TUNEL - an efficient prognosis predictor of salivary malignancies. 2007 Br. J. Cancer pmid:17325701
Zou L et al. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. 2007 Br. J. Cancer pmid:17940506
Hettiaratchi A et al. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. 2007 Br. J. Cancer pmid:17311017
Heng B et al. Human papilloma virus is associated with breast cancer. 2009 Br. J. Cancer pmid:19724278
Mc Cormack O et al. Growth arrest-specific gene 6 expression in human breast cancer. 2008 Br. J. Cancer pmid:18283315
Bilim V et al. Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis. 2008 Br. J. Cancer pmid:18283311
Ding SL et al. Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade. 2004 Br. J. Cancer pmid:15138484
Patmore HS et al. Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation? 2004 Br. J. Cancer pmid:15138481
Sivridis E et al. Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis. 2002 Br. J. Cancer pmid:11986782
Hildenbrand R and Arens N Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue. 2004 Br. J. Cancer pmid:15226768
Garcia S et al. c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. 2007 Br. J. Cancer pmid:17242702
Hagemann T et al. Molecular profiling of cervical cancer progression. 2007 Br. J. Cancer pmid:17242701
Bing C et al. Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. 2002 Br. J. Cancer pmid:11870545
Kato T et al. A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity. 2005 Br. J. Cancer pmid:16251871
Preuss SF et al. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. 2008 Br. J. Cancer pmid:18212752
Dai DL et al. Reduced Apaf-1 expression in human cutaneous melanomas. 2004 Br. J. Cancer pmid:15305193
Page K et al. Detection of HER2 amplification in circulating free DNA in patients with breast cancer. 2011 Br. J. Cancer pmid:21427727
Fontanini G et al. A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma. 2002 Br. J. Cancer pmid:11870537
Duanmu J et al. Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy. 2011 Br. J. Cancer pmid:21427724
Awwad HK et al. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. 2002 Br. J. Cancer pmid:11870530
Rosenthal AN et al. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma. 2003 Br. J. Cancer pmid:12610510
Rofstad EK and Halsør EF Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8. 2002 Br. J. Cancer pmid:11870523
Koumakpayi IH et al. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer. 2010 Br. J. Cancer pmid:20216540
Bruynzeel AM et al. Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice. 2007 Br. J. Cancer pmid:17325706
Cai H et al. Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo. 2004 Br. J. Cancer pmid:15316567
Bluff JE et al. Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. 2009 Br. J. Cancer pmid:19623180
Watermann DO et al. Specific induction of pp125 focal adhesion kinase in human breast cancer. 2005 Br. J. Cancer pmid:16136050
Gu C et al. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. 2004 Br. J. Cancer pmid:14735190
Ito Y et al. Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. 2004 Br. J. Cancer pmid:14735186
Mizukami Y et al. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. 2008 Br. J. Cancer pmid:18841157
Van der Auwera I et al. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. 2008 Br. J. Cancer pmid:18841156
Zheng HC et al. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. 2006 Br. J. Cancer pmid:17088917
Deans DA et al. Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. 2006 Br. J. Cancer pmid:17088911
Sheach LA et al. Androgen-related expression of G-proteins in ovarian cancer. 2009 Br. J. Cancer pmid:19623182
Cemazar M et al. The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification. 2005 Br. J. Cancer pmid:15970923
Bromwich EJ et al. The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. 2003 Br. J. Cancer pmid:14612901
Kawaraya M et al. Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancer. 2003 Br. J. Cancer pmid:14612897
Negishi T et al. NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel. 2006 Br. J. Cancer pmid:16909136
Debergh I et al. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. 2010 Br. J. Cancer pmid:20125158
Vlahovic G et al. Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation. 2006 Br. J. Cancer pmid:17003785
Jenkinson SR et al. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. 2004 Br. J. Cancer pmid:14710237
Sarbia M et al. The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus. 2007 Br. J. Cancer pmid:17940507
Lujan B et al. Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands. 2010 Br. J. Cancer pmid:20664595
Dufresne A et al. Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis. 2010 Br. J. Cancer pmid:20664593
Ugurel S et al. Lack of clinical efficacy of imatinib in metastatic melanoma. 2005 Br. J. Cancer pmid:15846297
Brown NS et al. Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma. 2005 Br. J. Cancer pmid:15841086
Chatrath P et al. Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. 2003 Br. J. Cancer pmid:12966424
Langbein S et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. 2006 Br. J. Cancer pmid:16465194
Kurokawa T et al. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. 2003 Br. J. Cancer pmid:12966423
Hudelist G et al. Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. 2003 Br. J. Cancer pmid:12966413
Lau ST et al. Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells. 2010 Br. J. Cancer pmid:20068565
Cellai I et al. In vivo effects of rosiglitazone in a human neuroblastoma xenograft. 2010 Br. J. Cancer pmid:20068562
Span PN et al. Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. 2003 Br. J. Cancer pmid:12865916
Mori N et al. Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer. 2010 Br. J. Cancer pmid:20664599
Hartana CA et al. Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours. 2016 Br. J. Cancer pmid:27599044
Cappello F et al. CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer. 2005 Br. J. Cancer pmid:15756258
Seenath MM et al. Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer. 2008 Br. J. Cancer pmid:18648372
Landers KA et al. Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. 2008 Br. J. Cancer pmid:18648369
Fondevila C et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. 2004 Br. J. Cancer pmid:14710231
Hashida H et al. Clinical significance of transmembrane 4 superfamily in colon cancer. 2003 Br. J. Cancer pmid:12838318
Yamamoto T et al. No major tumorigenic role for beta-catenin in serrated as opposed to conventional colorectal adenomas. 2003 Br. J. Cancer pmid:12838317
Benharroch D et al. Measles virus: evidence of an association with Hodgkin's disease. 2004 Br. J. Cancer pmid:15226778
Carpi A et al. Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology. 2006 Br. J. Cancer pmid:16804521
Górka B et al. NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas. 2007 Br. J. Cancer pmid:17667921